{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-009933","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2025-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.657956+00:00","generated_at":"2026-05-17T21:46:47.929306+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Iradimed reports record Q2 revenue of $20.4M (+14% YoY), raises FY2025 guidance","bullets":["GAAP diluted EPS of $0.45 (up 18% YoY); non-GAAP diluted EPS of $0.49 (up 17% YoY).","Declares regular quarterly cash dividend of $0.17 per share, payable Aug 28, 2025.","FY2025 revenue guidance raised to $80-82.5M; GAAP EPS to $1.60-1.70; non-GAAP EPS to $1.76-1.86.","Gross profit margin held at 78%; record backlog for pump and monitor products as of June 30, 2025.","Q3 2025 guidance: revenue $20.5-20.9M, GAAP EPS $0.41-0.45, non-GAAP EPS $0.45-0.49."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-009933","json":"https://secwatch.observer/filing/0001558370-25-009933.json","markdown":"https://secwatch.observer/filing/0001558370-25-009933.md","text":"https://secwatch.observer/filing/0001558370-25-009933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025009933/0001558370-25-009933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025009933/irmd-20250801x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:46:47.929306+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}